Latest Earnings Results: Q3 '26
Estimated EPS
-$0.18
Reported EPS
-$0.59
Surprise
-227.78%
Estimated Rev
$18.22M
Reported Rev
$19.12M
Surprise
+4.95%
• Reported GAAP EPS of -$0.07 down -800.00% YoY • Reported revenue of $19.12M up 20.03% YoY • Rockwell Medical says combination with Vantives global hemodialysis concentrates, hemodialysis machines, water treatment systems, related consumables and technical services business is projected to generate annual revenue between $400M and $450M.
Bullish Takeaway
Rockwell Medical reported higher quarterly sales from existing and new customers, higher gross profit and margin, and a proposed Vantive acquisition projected to add products, global reach and annual revenue.
Bearish Takeaway
Rockwell Medical reported a $2.3M net loss and $300K adjusted EBITDA loss, cash decreased from June 30, and Vantive completion and integration face stated uncertainties.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.11 | -- | -- | N/A |
Q3 '26 | -$0.18 | -$0.59 | -227.78% | MISSED |
Q2 '26 | -$0.23 | -$0.34 | -44.68% | MISSED |
Q1 '26 | -$0.03 | -$0.40 | -1500.00% | MISSED |
Q4 '25 | $0.02 | -$0.01 | -150.00% | MISSED |